基本信息
views: 10
Career Trajectory
Bio
In those positions, Dr. Taub oversaw clinical development and drug discovery programs in cardiovascular and metabolic diseases including the conduct of a series of Phase I and II proof of concept clinical trials. Dr. Taub led drug discovery, including target identification, lead optimization and advancement of preclinical candidates into clinical development. From 2000 through 2003, Dr. Taub worked at Bristol-Myers Squibb Co. and DuPont Pharmaceutical Company in a variety of positions, including Executive Director of CNS and metabolic diseases research. Before becoming a pharmaceutical executive, Dr. Taub was a tenured Professor of Genetics and Medicine at the University of Pennsylvania. Dr. Taub is the author of more than 120 research articles.
Research Interests
Papers共 116 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jörn M. Schattenberg,Quentin M. Anstee, Stephen A. Harrison, Mazen Noureddin,Rebecca Taub,Dominic Labriola, Jan Priel, Krishna Padmanabhan
Journal of Hepatology (2024)
Rohit Loomba,Jorn Schattenberg,Rebecca Taub,Dominic Labriola,Mazen Noureddin, Vlad Ratziu, Stephen A. Harrison
Gastroenterologyno. 5 (2024): S-1550
NEW ENGLAND JOURNAL OF MEDICINEno. 6 (2024): 497-509
The New England journal of medicineno. 17 (2024): 1632-1633
ALIMENTARY PHARMACOLOGY & THERAPEUTICSno. 1 (2024): 51-63
JOURNAL OF HEPATOLOGY (2023): S815-S816
HEPATOLOGY (2023): S766-S767
Cited0Views0Bibtex
0
0
Nature Medicineno. 11 (2023): 2919-2928
HEPATOLOGY (2023): S1207-S1213
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn